158 THE SEVERE AND PERSI STENT MENTAL ILLNESS PROGRESS NOTES PLAN NER B. The client was reinforced for following through on a referral to a physician for an assessment for a prescription of psychotropic medications, but none were prescribed. C. The client has been prescribed psychotropic medications. D. The client declined evaluation by a physician for a prescription of psychotropic medications and was re directed to cooperate with this referral. 13. Educate about Psychotropic Medications (1 3) A. The client was taught about the indications for and the expected benefits of psychotropic medications. B. As the client's psychotropic medications were reviewed, he/she displayed an understanding about the indications for and expected benefits of the medications. C. The client displayed a lack of understanding of the indications for and expected benefits of psychotropic medications and was provided with addition al information and feedback regarding his/her medications. 14. Monitor Medications (14) A. The client was monitored for compliance with his/her psychotropic medication regimen. B. The client was provided with positive feedback about his/her regular use of psychotropic medications. C. The client was monitored for the effectiveness and side effects of his/her prescribed medications. D. Concerns about the client's medication effectiveness and side effects were communicated to the physician. E. Although t he client was monitored for medication side effects, he/she reported no concerns in this area. 15. Review/Model Procurement of Medications ( 15) A. Protocol for procuring the client's medications was reviewed with him/her. B. The procurement of the clien t's medication was modeled to him/her. C. The client was shadowed for support as he/she procured his/her own medications. D. The client does not appropriately and regularly procure his/her own medications and was provided with additional training in this area. 16. Develop Agreement Regarding Monitoring of Medications ( 16) A. An agreement was developed with the client regarding the level of responsibility and independence that he/she must display to trigger a decrease in the clinician's monitoring of medications. B. The closeness with which the clinician monitors the client's medications has been decreased as he/she has displayed increased responsibility and independence. C. The client's medications continue to be closely monitored as he/she has failed to display the needed level of responsibility and independence. 17. Coordinate an Agreement with the Pharmacist ( 17) A. An agreement was coordinated between the client, the pharmacist, and the clinician regarding circumstances that would trigger a transf er of medication monitoring back to the clinician. 